People who experience a reduced visual field as a result of glaucoma or stroke can drive as safely as those of the same age with normal vision, a recent study finds. Medscape Medical News
Author: Medscape
This Gender Logs More Eye Surgeries in Residency
Records from more than 4800 ophthalmology residents show the average number of cataract surgeries and other eye procedures could vary by gender and race or ethnicity. Medscape Medical News
ARVO Attendees Hear Call to Save National Eye Institute
An eye research advocacy group has issued an urgent plea to thwart proposals to gut federal funding for biomedical research and dismantle the National Eye Institute. Medscape Medical News
How Climate Change Threatens Eye Health
Cataracts, pink eye, and other ocular disorders are linked to heat, air pollution, and higher UV exposure. Knowable Magazine
Cataract Surgery May Be Safe Beyond A1c Cutoffs
Cataract surgery may not increase the risk for postoperative endophthalmitis or severe systemic adverse events in patients with diabetes, regardless of A1c levels, according to a recent study. Medscape Medical News
MHRA Approves First UK Treatment for Thyroid Eye Disease
The Medicines and Healthcare products Regulatory Agency has approved teprotumumab, the first treatment to be licensed in the UK for adults with thyroid eye disease. Medscape News UK
Oral, Injected Semaglutide May Pose Distinct Eye Risks
The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which also identified differences based on sex, age, and timing of onset. Medscape Medical News
AAN 2025: The Impact of Updated Diagnostic Criteria in RRMS
Dr Pavan Bhargava comments on the practical implications of the revised diagnostic criteria, which allow for earlier diagnosis. Medscape
EMA Recommends Tepezza for Severe Thyroid Eye Disease
Teprotumumab is a fully human IgG1 monoclonal antibody that inhibits tissue inflammation and remodeling. Medscape Medical News
FDA Okays Upadacitinib for Giant Cell Arteritis
This is the first and only oral JAK inhibitor indicated for giant cell arteritis, according to the manufacturer AbbVie. Medscape Medical News
Red-Light Therapy May Reduce Cone Density in Myopic Children
Medscape Medical News
Are You Prescribing Acne Antibiotics Right? Key Tips
Optimize your acne treatment approach with these key tips on using antibiotics properly, combining therapies, and ensuring the best patient outcomes. Medscape Medical News
Young Women Binge Drinking at Higher Rates Than Men
Young women are binge drinking more than young men. Medscape Medical News
Stop Smoking Now to Protect Your Vision, Experts Warn
A “meta–meta-analysis” highlights the negative effects of smoking on ocular health, particularly concerning age-related macular degeneration, cataracts, and primary open-angle glaucoma. Medscape Medical News
UK Consultants Restore Sight for 24 Injured Protesters
Two consultants from London’s Moorfields Eye Hospital restored vision for 24 young men in Bangladesh, following severe eye trauma sustained during pro-democracy protests. Medscape News UK
Slow Adalimumab Tapering May Cut Risk for Uveitis Relapse
A retrospective cohort analysis shows that pediatric patients with noninfectious uveitis face lower recurrence rates when adalimumab is tapered slowly after remission. Medscape Medical News
JAK Inhibitors Offer Some Improvement for Pediatric Uveitis
Only half of patients showed clinical improvement attributed to the medication, but only one new complication occurred. Medscape Medical News
Probiotic Formula May Protect Infants With Milk Allergy
Children with cow’s milk protein allergy may have a lower incidence of allergic manifestations when their diet includes a probiotic-enhanced formula, new research shows. Medscape Medical News
Social Media Aids Post-Op Care in Ectopia Lentis
Using a smartphone application for health education and reminders enhances parental understanding and boosts follow-up visits in children undergoing surgery for CEL. Medscape Medical News
Modest Effects of Valacyclovir in Herpes Zoster Eye Disease
Administration of low-dose valacyclovir over a year does not significantly reduce the occurrence of herpes zoster ophthalmicus but shows potential benefits over time. Medscape Medical News